|
WO2020262057A1
|
|
Water-based adhesive patch
|
|
US2020330371A1
|
|
Transdermally administrable preparation
|
|
JP2020066592A
|
|
Aqueous patch
|
|
US2021085633A1
|
|
Rivastigmine-containing transdermal absorption preparation
|
|
WO2018155682A1
|
|
Transdermal preparation containing rivastigmine
|
|
US2019388360A1
|
|
Pharmaceutical patch comprising lidocaine and diclofenac for treating neuropathic pain
|
|
WO2018070406A1
|
|
Water-based adhesive patch
|
|
JP2019055928A
|
|
Patch
|
|
US2017231959A1
|
|
Ropinirole-containing adhesive patch
|
|
WO2017164381A1
|
|
Transdermal absorption-type patch preparation comprising zonisamide
|
|
JP2017039508A
|
|
Storage container
|
|
CA2949474A1
|
|
Transdermal preparation
|
|
JP2015155463A
|
|
Drug composition for iontophoresis
|
|
JP2016199521A
|
|
Brexpiprazole percutaneous absorption preparation
|
|
JP2016199522A
|
|
Celecoxib percutaneous absorption preparation
|
|
JP2016196426A
|
|
Fentanyl containing patch
|
|
EP3115044A1
|
|
Patch preparation
|
|
JP2015042665A
|
|
Non-steroid antiinflammatory patches
|
|
CA2920284A1
|
|
Beraprost-containing patch
|
|
JP2015221767A
|
|
Formulation for transdermal administration
|
